Richter Gedeon Vegyeszeti Gyar Nyrt
XMUN:RIG2
Relative Value
The Relative Value of one RIG2 stock under the Base Case scenario is hidden EUR. Compared to the current market price of 29.92 EUR, Richter Gedeon Vegyeszeti Gyar Nyrt is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
RIG2 Competitors Multiples
Richter Gedeon Vegyeszeti Gyar Nyrt Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| HU |
R
|
Richter Gedeon Vegyeszeti Gyar Nyrt
XMUN:RIG2
|
1.9T EUR | 2.1 | 8.6 | 5 | 6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
935.4B USD | 14.3 | 45.2 | 30.5 | 32.5 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.9B USD | 6.2 | 21.8 | 15.1 | 18.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
256.9B CHF | 4.2 | 19.8 | 11.7 | 13.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
233.7B CHF | 5.3 | 21.5 | 13.3 | 17.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
222.2B GBP | 5.1 | 29.1 | 16.1 | 22.7 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
288.9B USD | 4.4 | 15.8 | 9.8 | 12 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.6 | 10.8 | 8 | 9.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
152.2B USD | 2.4 | 19.5 | 7.5 | 10 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118.9B USD | 2.5 | 16.9 | 7.1 | 8.8 |